Loading
HitGen Inc.: what insiders have been doing
HitGen Inc. is a Health Care company. Its directors and officers file their transactions with SSE / SZSE (CSRC). HitGen Inc. has had no insider filing for more than a year; the last one goes back to 11 August 2021.
Over the whole record (from 2021), the tally stands at no purchases and 2 sales.
In the same sector, recent insider purchases at MAIA Biotechnology, Inc. and Cooper Companies, Inc. also feature in our signals. Source: insider filings from SSE / SZSE (CSRC). Past trades are no guide to future returns.
Insider Decl.
2
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€15M
2 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 10,823 of 24,166 companies
54.2
score / 100
Value38
Quality71
FCF yld0.3%
Earn yld0.7%
EV/EBITDA·
ROE9.4%
Gross mgn54%
Net mgn21%
Debt/EBITDA1.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
CN¥41.92
Analyst consensus
2 analystsCN¥42.20Target CN¥43.60(+4%)CN¥45.00
Income statement
RevenueCN¥525.6M
Gross profitCN¥285M54% margin
EBITDACN¥180.1M34% margin
Net incomeCN¥109.5M21.7% margin
Valuation
PER (trailing)119.8x
PER (forward)80.0x
P/Book11.0x
Beta0.58
Balance sheet & cash
Market capCN¥16.8B
Total debtCN¥234.3M
Free Cash FlowCN¥55.8M
Debt / Equity16%
Profitability & ownership
ROE9.4%
ROA5.1%
% insiders45.6%
% institutions5.5%
Last declaration on 11 August 2021
Declarations2 total
2,294,970 shares100.0% of flowA股XSHGSSE:173000004641980380
1,496,273 shares100.0% of flowA股XSHGSSE:173000004642039400
2 of 2 declarations
About HitGen Inc.
Chengdu Xian Dao is a company operating in the healthcare and pharmaceutical sector, listed on the XSHG market. It focuses on research and development of innovative solutions in the pharmaceutical field.
